Pedro González-Naranjo

Cannabinoid agonists showing BuChE inhibition as potential therapeutic agents for Alzheimer's disease

Pedro González-Naranjo, Natalia Pérez-Macías, Nuria E. Campillo et al. · European Journal of Medicinal Chemistry · 2013 · 50 citations · Full text

Cannabis Use, Psychoactive Drug, Alzheimer's Disease +15

Cannabinoid derivatives exert a potent anti-myeloma activity both<i>in vitro</i>and<i>in vivo</i>

María Victoria Barbado, Mayte Medrano, Teresa Caballero‐Velázquez et al. · International Journal of Cancer · 2016 · 35 citations · Full text

Potent Anti-myeloma Activity, Apoptosis, Immunology +24

Indazolylketones as new multitarget cannabinoid drugs

Pedro González-Naranjo, Natalia Pérez-Macías, Concepción Pérez et al. · European Journal of Medicinal Chemistry · 2019 · 20 citations · Full text

Cannabis Use, Psychoactive Drug, Medicine +5

Multitarget Cannabinoids as Novel Strategy for Alzheimer Disease

Pedro González-Naranjo, Nuria E. Campillo, Concepción Pérez et al. · Current Alzheimer Research · 2013 · 17 citations

Targeting Cannabinoid Receptor Activation and BACE-1 Activity Counteracts TgAPP Mice Memory Impairment and Alzheimer’s Disease Lymphoblast Alterations

Emilio Nuñez‐Borque, Pedro González-Naranjo, Fernando Benito Bartolomé et al. · Molecular Neurobiology · 2020 · 13 citations

Cannabis Use, Neurodegenerative Diseases, Alzheimer's Disease +15